PortfoliosLab logo
ZBH vs. VIAV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ZBH and VIAV is 0.53, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

ZBH vs. VIAV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Zimmer Biomet Holdings, Inc. (ZBH) and Viavi Solutions Inc. (VIAV). The values are adjusted to include any dividend payments, if applicable.

-100.00%0.00%100.00%200.00%300.00%December2025FebruaryMarchAprilMay
268.31%
-77.06%
ZBH
VIAV

Key characteristics

Sharpe Ratio

ZBH:

-0.80

VIAV:

0.60

Sortino Ratio

ZBH:

-0.91

VIAV:

1.09

Omega Ratio

ZBH:

0.87

VIAV:

1.16

Calmar Ratio

ZBH:

-0.44

VIAV:

0.25

Martin Ratio

ZBH:

-1.79

VIAV:

2.55

Ulcer Index

ZBH:

11.43%

VIAV:

9.62%

Daily Std Dev

ZBH:

25.99%

VIAV:

41.73%

Max Drawdown

ZBH:

-65.03%

VIAV:

-99.81%

Current Drawdown

ZBH:

-43.34%

VIAV:

-98.62%

Fundamentals

Market Cap

ZBH:

$20.25B

VIAV:

$2.07B

EPS

ZBH:

$4.43

VIAV:

$0.02

PE Ratio

ZBH:

23.11

VIAV:

467.00

PEG Ratio

ZBH:

1.27

VIAV:

2.41

PS Ratio

ZBH:

2.66

VIAV:

1.93

PB Ratio

ZBH:

1.63

VIAV:

2.77

Total Revenue (TTM)

ZBH:

$7.70B

VIAV:

$1.05B

Gross Profit (TTM)

ZBH:

$5.11B

VIAV:

$601.90M

EBITDA (TTM)

ZBH:

$1.79B

VIAV:

$89.70M

Returns By Period

In the year-to-date period, ZBH achieves a -9.77% return, which is significantly lower than VIAV's -9.21% return. Over the past 10 years, ZBH has underperformed VIAV with an annualized return of -0.63%, while VIAV has yielded a comparatively higher 2.60% annualized return.


ZBH

YTD

-9.77%

1M

-7.47%

6M

-12.11%

1Y

-20.60%

5Y*

-3.52%

10Y*

-0.63%

VIAV

YTD

-9.21%

1M

-4.58%

6M

-12.67%

1Y

24.93%

5Y*

-5.75%

10Y*

2.60%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ZBH vs. VIAV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ZBH
The Risk-Adjusted Performance Rank of ZBH is 1313
Overall Rank
The Sharpe Ratio Rank of ZBH is 1111
Sharpe Ratio Rank
The Sortino Ratio Rank of ZBH is 1515
Sortino Ratio Rank
The Omega Ratio Rank of ZBH is 1313
Omega Ratio Rank
The Calmar Ratio Rank of ZBH is 2424
Calmar Ratio Rank
The Martin Ratio Rank of ZBH is 22
Martin Ratio Rank

VIAV
The Risk-Adjusted Performance Rank of VIAV is 7171
Overall Rank
The Sharpe Ratio Rank of VIAV is 7575
Sharpe Ratio Rank
The Sortino Ratio Rank of VIAV is 6868
Sortino Ratio Rank
The Omega Ratio Rank of VIAV is 7070
Omega Ratio Rank
The Calmar Ratio Rank of VIAV is 6464
Calmar Ratio Rank
The Martin Ratio Rank of VIAV is 7777
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ZBH vs. VIAV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Zimmer Biomet Holdings, Inc. (ZBH) and Viavi Solutions Inc. (VIAV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current ZBH Sharpe Ratio is -0.80, which is lower than the VIAV Sharpe Ratio of 0.60. The chart below compares the historical Sharpe Ratios of ZBH and VIAV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00December2025FebruaryMarchAprilMay
-0.80
0.60
ZBH
VIAV

Dividends

ZBH vs. VIAV - Dividend Comparison

ZBH's dividend yield for the trailing twelve months is around 1.01%, while VIAV has not paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
ZBH
Zimmer Biomet Holdings, Inc.
1.01%0.91%0.79%0.75%0.76%0.62%0.64%0.93%0.80%0.93%0.86%0.78%
VIAV
Viavi Solutions Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%77.01%0.00%

Drawdowns

ZBH vs. VIAV - Drawdown Comparison

The maximum ZBH drawdown since its inception was -65.03%, smaller than the maximum VIAV drawdown of -99.81%. Use the drawdown chart below to compare losses from any high point for ZBH and VIAV. For additional features, visit the drawdowns tool.


-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%December2025FebruaryMarchAprilMay
-43.34%
-83.56%
ZBH
VIAV

Volatility

ZBH vs. VIAV - Volatility Comparison

The current volatility for Zimmer Biomet Holdings, Inc. (ZBH) is 14.50%, while Viavi Solutions Inc. (VIAV) has a volatility of 16.52%. This indicates that ZBH experiences smaller price fluctuations and is considered to be less risky than VIAV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%December2025FebruaryMarchAprilMay
14.50%
16.52%
ZBH
VIAV

Financials

ZBH vs. VIAV - Financials Comparison

This section allows you to compare key financial metrics between Zimmer Biomet Holdings, Inc. and Viavi Solutions Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


500.00M1.00B1.50B2.00B20212022202320242025
1.91B
284.80M
(ZBH) Total Revenue
(VIAV) Total Revenue
Values in USD except per share items

ZBH vs. VIAV - Profitability Comparison

The chart below illustrates the profitability comparison between Zimmer Biomet Holdings, Inc. and Viavi Solutions Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

55.0%60.0%65.0%70.0%20212022202320242025
63.3%
56.4%
(ZBH) Gross Margin
(VIAV) Gross Margin
ZBH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Zimmer Biomet Holdings, Inc. reported a gross profit of 1.21B and revenue of 1.91B. Therefore, the gross margin over that period was 63.3%.

VIAV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Viavi Solutions Inc. reported a gross profit of 160.70M and revenue of 284.80M. Therefore, the gross margin over that period was 56.4%.

ZBH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Zimmer Biomet Holdings, Inc. reported an operating income of 338.90M and revenue of 1.91B, resulting in an operating margin of 17.8%.

VIAV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Viavi Solutions Inc. reported an operating income of 8.50M and revenue of 284.80M, resulting in an operating margin of 3.0%.

ZBH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Zimmer Biomet Holdings, Inc. reported a net income of 182.00M and revenue of 1.91B, resulting in a net margin of 9.5%.

VIAV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Viavi Solutions Inc. reported a net income of 19.50M and revenue of 284.80M, resulting in a net margin of 6.9%.